Show simple item record

FieldValueLanguage
dc.contributor.authorRischin, A.en
dc.contributor.authorLiew, D.en
dc.contributor.authorBlack, R.en
dc.contributor.authorFletcher, A.en
dc.contributor.authorBuchbinder, R.en
dc.contributor.authorLassere, M.en
dc.contributor.authorMarch, L.en
dc.contributor.authorRobinson, P.C.en
dc.contributor.authorHill, C.en
dc.contributor.authorBarrett, C.en
dc.contributor.authorCarroll, G.en
dc.contributor.authorMarine, F.en
dc.contributor.authorSchachna, L.en
dc.contributor.authorSinnathurai, P.en
dc.contributor.authorThe ARAD Steering Committeeen
dc.date.accessioned2021-06-25T05:24:54Z
dc.date.available2021-06-25T05:24:54Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/2123/25498
dc.description.abstractommunity restrictions due to COVID-19 have changed healthcare, including increased telehealth use. During the early pandemic phase, a cohort of Australian patients with inflammatory arthritis was surveyed. Self-reported access to healthcare was maintained and physical health was more likely to be self-rated poorly than mental health. There was a high level of support for telehealth during and after the pandemic.en
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleHealthcare access and attitudes towards telehealth during the early phase of the COVID-19 pandemic among an Australian cohort with inflammatory arthritisen
dc.typeArticleen
dc.identifier.doi10.1111/imj.15309
dc.relation.otherAstraZenecaen
dc.relation.otherRocheen
dc.relation.otherNHMRC 384330en
dc.relation.otherPfizer Australiaen
dc.relation.otherMonash Universityen
usyd.facultySeS faculties schools::Faculty of Medicine and Healthen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.